Drug-induced liver injury due to "natural products" used for weight loss: a case report. by Tarantino G et al.
www.wjgnet.com
 CASE REPORT
Drug-induced liver injury due to “natural products” used for 
weight loss: A case report
Giovanni Tarantino, Martina Gilda Pezzullo, Matteo Nicola Dario di Minno, Francesco Milone, 
Luigi Sossio Pezzullo, Marco Milone, Domenico Capone
Online Submissions: wjg.wjgnet.com                                        World J Gastroenterol  2009 May 21; 15(19): 2414-2417
wjg@wjgnet.com                                                                                               World Journal of Gastroenterology  ISSN 1007-9327
doi:10.3748/wjg.15.2414                                                                                           © 2009 The WJG Press and Baishideng. All rights reserved.
Giovanni Tarantino, Matteo Nicola Dario di Minno, 
Department of Clinical & Experimental Medicine, Federico II 
University Medical School, Via S. Pansini, 5 80131 Naples, Italy
Martina Gilda Pezzullo, Luigi Sossio Pezzullo, Department 
of General Surgery, Federico II University Medical School, 
5 80131 Naples, Italy
Francesco M i lone , Marco M i lone , Depar tment of 
Neuroscience, Section of Clinical Pharmacology, Federico II 
University Medical School, 5 80131 Naples, Italy
Domenico Capone, Department of General Surgery, ASL BN1 
of Benevento, 5 80131 Naples, Italy
Author contributions: All authors analyzed and interpreted the 
patient data and made a major contribution to the writing of the 
manuscript. All authors read and approved the final manuscript.
Correspondence to: Giovanni Tarantino, MD, Department 
of Clinical & Experimental Medicine, Federico II University 
Medical School, Via S. Pansini, 5 80131 Naples, 
Italy. tarantin@nina.it
Telephone: +39-81-7462024  Fax: +39-81-5466152
Received: January 10, 2009    Revised: April 10, 2009
Accepted: April 17, 2009
Published online: May 21, 2009
Abstract
Tak ing he rba l - ex t rac t s t o l o se we igh t i s an 
underestimated health hazard. Often, these products 
contain active agents that can cause acute liver 
damage. In this case report, a 22-year-old female 
patient, who presented with a feature of cholestatic 
syndrome, was so sure that the “natural products” 
were not dangerous that she did not inform her 
physicians that she had taken them, making their task 
that much more challenging. Clinical presentation 
mimicked acute cholecyst i t i s and the pat ient 
underwent a cholecystectomy. Surgery was without 
any consequences and complications, although it did 
not completely cure the illness. She later admitted 
to having taken herbal remedies and this led to the 
correct diagnosis of phytotherapy-related hepatotoxicity 
and a successful therapeutic approach. The true 
incidence of phytotherapy-related hepatotoxicity and 
its pathogenic mechanisms are largely unknown. It is 
important to increase the awareness of both clinicians 
and patients about the potential dangers of herbal 
remedies.
© 2009 The WJG Press and Baishideng. All rights reserved.
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INTRODUCTION
The desire to lose weight using “natural products” and 
the availability of  these items can induce pathologies, 
the causes of  which are often overlooked. The main 
problem with “natural products” is that the exact 
quantity and purity of  a given ingredient contained in 
extracts of  vegetable origin (mainly herbs) are largely 
unknown. It can happen that patients deny taking these 
products, thinking that they are “safe” because they are 
“natural” and thus physicians do not have the key facts 
to interpret dangerous pathologies. Here we report a 
case of  a patient who experienced jaundice and pruritus, 
not assuming the “natural products” was at fault, with 
a clinical presentation highly suggestive of  cholecystitis 
whose final diagnosis turned out to be drug-induced 
liver injury (DILI).
CASE REPORT
A 22-year-old obese (BMI 32) woman presented to 
hospital in May 2007 with a cholestatic syndrome 
of  unknown origin. Her only declared pre-existing 
medication was paracetamol (500 mg daily), used as an 
analgesic for menstrual pain. Pre-admission blood tests 
were normal.
Symptoms included jaundice, pruritus, right upper 
quadrant pain and epigastric tenderness, accompanied 
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by fever of  low grade, nausea, vomiting, dark urine and 
pale stools. At the time of  admission routine liver enzyme 
tests revealed bilirubin 128 μmol/L (< 20 μmol/L), 
alkaline phosphatase (ALP) 1229 U/L (40-110 U/L), 
γ-glutamyltransferase (GGT) 293 U/L (< 50 U/L), 
Aspartic-aminotransferase (AST) 1378 U/L (< 45 U/L) 
and Alanine-aminotransferase (ALT) 1686 U/L (< 
40 U/L). She had never consumed alcohol and there 
was no recent travel history. Viral serology for hepatitis 
and HIV were negative. An infection screen was carried 
out because our country has an increasing incidence 
of  exotic illnesses due to recent immigration that can 
cause transient liver enzyme derangement. This panel 
included cytomegalovirus, Epstein-Barr virus, Flavivirus, 
Dengue virus, Ross River virus, Barmah Forest virus, 
Spotted fever virus, Scrub Typhus, and Leptospirosis 
serology; all of  them were unremarkable. Serum copper 
and caeruloplasmin, α-fetoprotein, α-1 antitrypsin, 
iron deposits were in the normal range. Anti-nuclear 
antibodies, perinuclear antineutrophil cytoplasmic 
antibodies, antibodies to liver kidney microsomal antigen 
type-1, anti-mitochondrial and anti-smooth muscle 
antibodies were negative. Her complete blood count was 
slightly abnormal. In fact, a modest increase in WBCs 
without left shift was present on admission, concurrent 
with an increase in eosinophils (7%) and a decrease in 
lymphocyte counts.
Abdominal ultrasound revealed the presence of  
microcalculi in the gallbladder. No clear dilatation of  the 
common bile duct was seen, but the exam was performed 
in the presence of  marked abdominal meteorism.
A magnetic resonance cholangio-pancreatography 
(MRC) indicated a dilatation of  the choledocus with 
a likely interruption of  its terminal tract, with some 
evidence of  microstones in the gallbladder (Figure 1). 
Consequently, physicians empirically treated this illness 
by imipenem/cilastatin (500/500 mg every 6 h) for 
seven days.
A negative history of  drug use, the physical findings 
(i.e. right upper quadrant and epigastric tenderness in 
the absence of  peritoneal findings), laboratory data 
(i.e. elevated levels of  bilirubin, alkaline phosphatase, 
ALT, and γ-glutamyltransferase) were consistent 
with extrahepatic obstruction, suggesting stones 
complicated by acute cholecystitis. Therefore, to gain 
access to and/or remove impacted common bile duct 
(CBD) stones at the ampulla of  Vater, the patient was 
submitted to a preoperative endoscopic retrograde 
cholangiopancreatography (ERCP) with endoscopic 
sphincterotomy and extraction of  sand-like stones.
Using this standard therapy, her laboratory data 
improved, with AST and ALT values of  1110 U/L and 
1225 U/L, respectively. At this point, a laparoscopic 
operative CBD exploration with mini-invasive technique 
was planned.
The abdominal inspection showed the presence 
of  extensive visceral adherences, as well as a general 
aspect of  diffuse bowel inflammation. The gallbladder 
was reddish-colored with a thick wall and bled easily. 
This was suggestive of  a complex abdominal pathology, 
therefore a conversion to an open procedure was chosen. 
Abdominal exploration and biliary manometry 
caused the surgeons to utilize an ante-grade trans-
ampullary intra-operative endobiliary stenting. The 
macroscopic examination showed acute cholecystitis 
with moderate wall-thickening containing very dense bile 
and some small stones.
The postoperative course was pain-free and the 
patient was prematurely discharged with drastically 
reduced (though elevated compared to normal) 
enzymatic values of  AST 108 U/L and ALT 156 U/L. 
Four days later the patient underwent liver laboratory 
tests that underlined an elevation of  the transaminases, 
with an AST level of  644 U/L, ALT of  810 U/L, 
AP of  806 U/L and bilirubin of  64 μmol/L, mainly 
unconjugated with a persistently draining T-tube.
An interrogation of  the woman’s relatives highlighted 
that the patient had taken several doses of  a phyto-
preparation in solution, bought from a store run by an 
herbalist, labeled as “herbal therapy for losing weight”. 
Fortunately, the relatives found this preparation, containing 
“Lycopodium serratum and Chelidonium maius” at 
home. The Roussel Uclaf  Causality Assessment Method, 
also known as Danan’s international consensus criteria[1], 
was developed to quantify the strength of  association 
between liver injury and herbal remedies and implicated 
the phyto-preparation as causing the injury. The case was 
adjudicated by three reviewers (DC, GT, MND) working 
independently and the patient was diagnosed as likely to 
be suffering from DILI. One month after given up taking 
the herbal remedy, all the liver parameters returned to 
normal values, without any apparent consequences. The 
case was re-adjudicated after a four-week follow-up by the 
same reviewers and the diagnosis was confirmed.
DISCUSSION
The “chelidonium majus” belongs to the family of  
papaveraceae; its roots contain the biologically active 
components chelerythrine and sanguinarine. The active 
“principia” are similar to those of  opium, and have well-
known hepatotoxic effects[2-4], although in animals an 
average daily oral dose of  alkaloids up to 5 mg/kg has 
Figure 1  Magnetic resonance cholangio-pancreatography showing 
dilatation of the choledocus and mimicking an interruption of its terminal 
tract, with some evidence of microstones in the gallbladder (arrows). 
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been proven to be safe[5].
The herb “Lycopodium serratum” has several[6] active 
agents that can cause hepatotoxicity[7]. The hepatic damage 
caused by these agents, generally of  a cholestatic type, is 
possibly mediated by an idiosyncratic or hypersensitivity 
reaction. Recently, a different hypothesis was proposed 
involving an impairment of  mitochondrial respiration[8].
Although this is not the first case reported in the 
literature, its importance lies in the atypical presentation. 
Indeed, was this a case of  misdiagnosis, the co-existence 
of  two diseases or an uncommon manifestation of  DILI 
with a clinical presentation mimicking an other disease? 
The results of  liver laboratory tests and imaging studies 
were attributed to an earlier combination of  symptomatic 
gallstones and cholangitis and the patient was treated 
accordingly. Unfortunately, a liver biopsy, which would 
have indicated the presence of  canalicular cholestasis with 
bile plugs in dilated canaliculi, occasional portal tracts 
containing a prominent lymphocytic infiltrate with mild 
piecemeal necrosis, was not performed and consequently 
the opportunity for a definitive diagnosis was lost.
Gallstone disease remains one of  the most common 
medical problems. The risk factors predisposing to 
gallstone formation include obesity, diabetes mellitus, 
estrogen and pregnancy, hemolytic diseases, and cirrhosis. 
Acute cholecystitis can carry the risk of  complications, 
including empyema, perforation, abscess, peritonitis and 
sepsis. Acute cholecystitis also causes acute pain in the right 
upper quadrant (RUQ). However, cross-sectional imaging 
is essential, because more than one-third of  patients with 
acute RUQ pain do not have acute cholecystitis. Today, 
laparoscopic cholecystectomy, laparoscopic common bile 
duct exploration, and endoscopic retrograde management 
of  CBD stones play important roles in the treatment 
of  gallstones, even though the treatment of  choice 
remains cholecystectomy. However, when asymptomatic 
gallstones are detected during the evaluation of  a patient, 
a prophylactic cholecystectomy is normally not indicated 
because of  several factors. Only about 30% of  patients 
with asymptomatic cholelithiasis will warrant surgery during 
their lifetime, suggesting that cholelithiasis is a relatively 
benign condition in some people. 
The main question we should ask ourselves is: was 
surgery the right choice? Although the patient’s symptoms 
and signs were extremely atypical for establishing the 
diagnosis of  acute cholecystitis in this young immune-
competent patient, her declaration of  not having taken 
any other medications, including over-the-counter 
medications, herbal or traditional medicines, definitely 
misled physicians. The late admission by her parents 
allowed a correct diagnosis of  DILI and not acute 
cholecystitis. Given the diagnosis of  DILI, the patient 
took a further risk with anesthesia.
Should physicians have performed further studies 
before surgery? A CT cholangiogram would have shown 
contrast material being excreted by the renal tract, 
suggesting that the pathology concerned hepatocellular 
damage rather than a biliary obstruction.
Was the patient incautiously discharged from the 
surgery unit? The answer is probably yes, because the 
reduction of  liver enzymatic activity caused surgeons to 
underestimate the pathology, with overconfidence in the 
previous diagnosis of  cholecystitis. 
There are many examples of  hepatotoxicity induced 
by herbal remedies, which have been widely used 
in recent decades as weight loss agents. Germander 
(Teucrium chamaedrys) extracts cause DILI, probably 
mediated by furano neoclerodane diterpenoids[9]. 
Chaparral is a desert shrub traditionally used by Native 
Americans for treatment of  several ailments. Recently, 
preparations of  chaparral leaves have been marketed as 
weight loss agents. The mechanism of  chaparral toxicity 
involves its active ingredient, nordihydroguaiaretic 
acid[10]. Kava (kava kava, awa, or kew), derived from 
the dried root and rhizome of  Piper methysticum, 
has recently been marketed as an anxiolytic and mood 
enhancer. Recent studies from Europe have described 
cases of  kava-associated hepatic injury. The mechanism 
of  hepatic injury appears to be immune-mediated, 
with CYP2D6 deficiency perhaps being a risk factor[11]. 
Herba Ephedrae (from Ephedra sinica and other Ephedra 
species) is a traditional Chinese extract also used 
for treatment of  asthma, nasal congestion, and fever. 
Although most adverse effects of  Herba Ephedrae are 
cardiovascular or neurological, 4% of  reports mentioned 
acute hepatitis. Herba Ephedrae contains phytochemicals, 
which are thought to strengthen its toxic activity[12].
In addition to the above supplements, liver injury 
has been attributed to other botanical agents. The 
pyrrolizidine alkaloids found in comfrey leaves and 
Heliotropium, Senecio, and Crotalaria species are known 
to cause veno-occlusive disease of  the liver via a toxic 
effect[13]. Mixtures of  valerian and skullcap (Valeriana 
officinalis and Scutellaria lateriflora) have induced 
hepatitis via alkylating agents. LipoKinetix was marketed 
as a dietary supplement for weight loss. Hepatic injury 
appears to be due to an idiosyncratic reaction, perhaps 
related to phenylpropanolamine[14]. Among other weight 
loss agents, Usnic acid should be suspected in case of  
severe hepatotoxicity[15]. 
In our case, the patient was sure the product was 
harmless and denied the use of  a potentially dangerous 
product in her history, thus not allowing physicians to 
discover the etiology of  the serious pathology from which 
she suffered. Only an accurate interrogation of  relatives 
was able to discover the relationship between the herbal 
remedy and DILI. 
The diagnostic approach was, in spite of  the lack of  a 
certain etiology, the most cautious possible; in fact, MRC 
and ERCP, perfectly framed into the clinical picture of  
this patient, are generally considered investigations of  first 
level. 
The prevalence of  adverse drug reactions (ADR) 
in health care systems has generated immense interest 
in recent years. Some of  these adverse events are 
completely unpredictable, but some result from medical 
errors, patient’s negligence or ignorance, and may occur 
anywhere and at anytime in the health care processes. 
However, a majority of  them may be preventable. The 
consequences of  these ADRs might vary, from little or 
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no harm to ultimately being fatal to the patients.
Patient safety has received increased attention 
in recent years, but most ly with a focus on the 
epidemiology, rather than on practices that reduce (1) 
ADRs, (2) adverse events related to exposure to herbal 
remedies and dietary supplements and (3) invasive 
procedures in medical care involving a wide spectrum 
of  diagnoses or conditions. Potential safety practices 
should be identified, based on preliminary surveys of  
the literature and expert consultation. 
The misdiagnosis of  DILI has many ramifications. 
These include medical and psychological implications 
for patients and their families, and financial and public 
health implications for health-care institutions.
The pat ient could have sued the heal th care 
practitioners (specifically the surgeons) if  she felt she had 
been injured. However, successful medical malpractice 
lawsuits require proof  of  the following items: the care 
provided was below the ordinary standard of  care that 
would be provided by similar health care practitioners 
under similar circumstances and the patient was harmed 
because of  the deviation from the standard of  care. In our 
case, concerns about lawsuits did not arise, because the 
physicians’ actions were in the best interests of  the patient. 
In fact, a good defence against malpractice lawsuits is to 
provide excellent medical care and to build close, trusting, 
and collaborative relationships with patients.
As a final consideration, patients should be especially 
cautious about using drugs, and should inform their 
doctor about any drugs or other substances they are 
taking, including prescription and over-the-counter 
medications, recreational drugs, herbal remedies, and 
nutritional supplements. Health care professionals are 
encouraged to report all ADRs, especially hepatotoxicity 
and to pay much more attention in prescribing and 
administering drugs.
For the vegetal abstracts, it should be mandatory to 
correctly describe their contents, taking in account the 
active ingredients, the real quantity per unit of  product 
contained with the preparation, and to make clear any 
possible side effects. 
In conclusion, the authors believe that a detailed, 
painstaking and meticulous history could have unveiled 
the underlying condition and the patient would not 
have been subjected to invasive and potentially harmful 
interventions. This is probably the most important 
learning point that emerged from this case report.
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